STOCK TITAN

Director at Corvex (MOVE) exercises stock options at $0.92

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Corvex, Inc. director Ruben Caballero exercised stock options to acquire 29,197 shares of Common Stock at an exercise price of $0.92 per share. Following this derivative exercise, his direct holdings increased to 38,017 Common shares. The filing notes that both the share amounts and exercise price reflect adjustments from a prior stock dividend and were tied to an option award under the company’s Omnibus Incentive Plan.

Positive

  • None.

Negative

  • None.
Insider Caballero Ruben
Role null
Type Security Shares Price Value
Exercise Stock Options (Right to Buy) 29,197 $0.00 --
Exercise Common Stock 29,197 $0.92 $27K
Holdings After Transaction: Stock Options (Right to Buy) — 0 shares (Direct, null); Common Stock — 38,017 shares (Direct, null)
Footnotes (1)
  1. As a result of the Company's stock dividend, each share of Common Stock issued and outstanding at the close of business on March 30, 2026 was automatically converted into 1.358 shares of Common Stock and was distributed on approximately April 6, 2026. The amounts reported on this Form 4 reflect the impacts of such stock dividend. This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025. The number of subject shares and the exercise price of such option award has been adjusted by the stock dividend.
Shares acquired via option exercise 29,197 shares Common Stock acquired through derivative exercise on 2026-06-25
Exercise price $0.92 per share Exercise price for stock options (right to buy) converted into Common Stock
Shares owned after transaction 38,017 shares Total direct Common Stock holdings following the transaction
Option expiration date June 30, 2026 Scheduled expiration date of the exercised stock options
Underlying option shares 29,197 shares Underlying Common Stock covered by the exercised option award
stock dividend financial
"As a result of the Company's stock dividend, each share of Common Stock issued and outstanding..."
A stock dividend is when a company gives its existing shareholders extra shares instead of cash. It’s like receiving more pieces of the same pie rather than a bigger piece of money, which can increase the number of shares you own but usually doesn’t change the total value of your investment right away. Investors care about it because it can signal the company's growth and affect the stock’s price.
Omnibus Incentive Plan financial
"This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan..."
An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.
exercise price financial
"The number of subject shares and the exercise price of such option award has been adjusted by the stock dividend."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Stock Options (Right to Buy) financial
"Stock Options (Right to Buy) ... underlying security title Common Stock, underlying security shares 29197.0000"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Caballero Ruben

(Last)(First)(Middle)
C/O CROVEX, INC.
3401 NORTH FAIRFAX DRIVE, SUITE 3230

(Street)
ARLINGTON VIRGINIA 22226

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Corvex, Inc. [ MOVE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/25/2026M29,197A$0.9238,017(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Buy)$0.9206/25/2026M29,197 (2)06/30/2026Common Stock29,197$0.000D
Explanation of Responses:
1. As a result of the Company's stock dividend, each share of Common Stock issued and outstanding at the close of business on March 30, 2026 was automatically converted into 1.358 shares of Common Stock and was distributed on approximately April 6, 2026. The amounts reported on this Form 4 reflect the impacts of such stock dividend.
2. This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025. The number of subject shares and the exercise price of such option award has been adjusted by the stock dividend.
/s/ Ruben Caballero by Mark R. Busch, attorney-in-fact06/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Corvex (MOVE) director Ruben Caballero report in this Form 4?

Ruben Caballero reported exercising stock options to acquire 29,197 Corvex Common shares at $0.92 per share. After this derivative exercise, his direct ownership increased to 38,017 Common shares, according to the Form 4 filing’s post-transaction holdings figure.

How many Corvex (MOVE) shares did Ruben Caballero acquire and at what price?

He acquired 29,197 shares of Corvex Common Stock through a stock option exercise at an exercise price of $0.92 per share. These shares came from an existing option award adjusted for a prior stock dividend described in the filing’s footnotes.

What are Ruben Caballero’s Corvex (MOVE) holdings after the reported transaction?

After exercising options, Ruben Caballero directly holds 38,017 shares of Corvex Common Stock. This post-transaction figure reflects the completed derivative exercise and incorporates the effects of the company’s previously declared stock dividend on share counts.

What type of security did Ruben Caballero exercise in Corvex (MOVE)?

He exercised “Stock Options (Right to Buy)” covering 29,197 underlying Common shares. The options had an exercise price of $0.92 per share and, after being exercised, left him with zero remaining options from this particular grant, per the Form 4 data.

How did Corvex’s stock dividend affect this Corvex (MOVE) Form 4?

The filing notes that a stock dividend converted each Common share into 1.358 shares and was distributed around April 6, 2026. The reported option share amounts and exercise price have been adjusted to reflect this stock dividend’s impact on the award.

What is the expiration date of the exercised Corvex (MOVE) stock options?

The exercised stock options were scheduled to expire on June 30, 2026. The Form 4 shows that, following the exercise of 29,197 options at $0.92 per share, zero options from this specific award remained outstanding for Ruben Caballero.